Alnylam Pharmaceuticals, Inc.
US ˙ NasdaqGS ˙ US02043Q1076

SecurityALNY / Alnylam Pharmaceuticals, Inc.
InstitutionSimplex Trading, Llc
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Simplex Trading, Llc ownership in ALNY / Alnylam Pharmaceuticals, Inc.

On August 5, 2025 - Simplex Trading, Llc filed a 13F-HR form disclosing ownership of 0 shares of Alnylam Pharmaceuticals, Inc. (US:ALNY) valued at $0 USD as of June 30, 2025. The entity filed a previous 13F-HR on May 12, 2025 disclosing 6,704 shares of Alnylam Pharmaceuticals, Inc.. This represents a change in shares of -100.00% during the quarter. The current value of the position is $0 USD.

Simplex Trading, Llc has a history of taking positions in derivatives of the underlying security (ALNY) in the form of stock options. The firm currently holds call options representing 16,900 of underlying shares valued at $5,591,703 USD and put options representing 18,200 of underlying shares valued at $6,021,834 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

ALNY / Alnylam Pharmaceuticals, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-08-05 2025-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 0 -6,704 -100.00 0 -100.00
2025-05-12 2025-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 6,704 1,875 38.83 2 0.00 0.0012
2025-02-11 2024-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 4,829 4,829 1 0.0006
2024-11-08 2024-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 0 -8,803 -100.00 0 -100.00
2024-07-25 2024-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 8,803 8,803 2 0.0013
2024-04-25 2024-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 0 -2,916 -100.00 0 0.0000
2024-02-02 2023-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 2,916 -3,929 -57.40 1 -100.00 0.0004
2023-11-01 2023-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 6,845 6,845 1 0.0010
2023-08-04 2023-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 0 -13,723 -100.00 0 -100.00
2023-04-27 2023-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 13,723 4,846 54.59 3 0.00 0.0024
2023-02-02 2022-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 8,877 8,868 98,533.33 2 100.00 0.0023
2022-11-04 2022-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 9 -1,068 -99.16 1 -99.36 0.0000
2022-08-03 2022-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 1,077 1,077 157 0.0002
2022-05-02 2022-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 0 -15,991 -100.00 0 -100.00
2022-02-04 2021-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 15,991 0 0.00 2,714 0.00 0.0025
2021-10-28 2021-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 15,991 707 4.63 2,714 4.79 0.0025
2021-08-12 2021-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 15,284 898 6.24 2,590 27.52 0.0025
2021-04-26 2021-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 14,386 6,311 78.15 2,031 93.61 0.0036
2021-02-02 2020-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 8,075 7,806 2,901.86 1,049 2,589.74 0.0014
2020-10-14 2020-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 269 269 -96.67 39 -96.28 0.0001
2020-07-13 2020-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 0 -14,470 -100.00 0 -100.00
2020-04-29 2020-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 14,470 14,470 1,575 0.0028
2019-07-26 2019-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 0 -2,772 -100.00 0 -100.00
2019-04-18 2019-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 2,772 2,772 259 0.0007
2018-04-26 2018-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 0 -5,971 -100.00 0 -100.00
2018-01-10 2017-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 5,971 -6,423 -51.82 758 -47.94 0.0326
2017-10-25 2017-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 12,394 12,394 107.57 1,456 92.08 0.0595
2017-07-12 2017-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 0 -32,718 -100.00 0 -100.00
2017-04-21 2017-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 32,718 24,987 323.21 1,676 479.93 0.0725
2017-01-11 2016-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 7,731 -1,025 -11.71 289 -51.26 0.0173
2016-10-07 2016-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 8,756 -5,994 -40.64 593 -27.51 0.0402
2016-07-18 2016-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 14,750 7,648 107.69 818 83.82 0.0547
2016-04-14 2016-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 7,102 7,102 -51.85 445 -45.60 0.0355
2016-01-20 2015-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 0 -4,335 -100.00 0 -100.00
2015-10-08 2015-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 4,335 -3,548 -45.01 348 -63.14 0.0255
2015-07-08 2015-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 7,883 7,883 81.85 944 171.26 0.0791
2015-04-21 2015-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 0 -853 -100.00 0 -100.00
2015-03-04 2014-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 853 853 83 0.0101
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-14 2026-03-31 13F ALNYLAM PHARMACEUTICALS CALL Call 16,900 33.07 5,592 10.71 n/a n/a n/a
2026-02-11 2025-12-31 13F ALNYLAM PHARMACEUTICALS CALL Call 12,700 -25.73 5,050 72,042.86 n/a n/a n/a
2025-11-12 2025-09-30 13F ALNYLAM PHARMACEUTICALS CALL Call 17,100 24.82 8 75.00 n/a n/a n/a
2025-08-05 2025-06-30 13F ALNYLAM PHARMACEUTICALS CALL Call 13,700 -56.78 4 -50.00 n/a n/a n/a
2025-05-12 2025-03-31 13F ALNYLAM PHARMACEUTICALS CALL Call 31,700 15.27 9 33.33 n/a n/a n/a
2025-02-11 2024-12-31 13F ALNYLAM PHARMACEUTICALS CALL Call 27,500 -27.44 6 -40.00 n/a n/a n/a
2024-11-08 2024-09-30 13F ALNYLAM PHARMACEUTICALS CALL Call 37,900 -57.13 10 -52.38 n/a n/a n/a
2024-07-25 2024-06-30 13F ALNYLAM PHARMACEUTICALS CALL Call 88,400 -42.30 21 -4.55 n/a n/a n/a
2024-04-25 2024-03-31 13F ALNYLAM PHARMACEUTICALS CALL Call 153,200 202.17 23 144.44 n/a n/a n/a
2024-02-02 2023-12-31 13F ALNYLAM PHARMACEUTICALS CALL Call 50,700 119.48 10 125.00 n/a n/a n/a
2023-11-01 2023-09-30 13F ALNYLAM PHARMACEUTICALS CALL Call 23,100 0.87 4 0.00 n/a n/a n/a
2023-08-04 2023-06-30 13F ALNYLAM PHARMACEUTICALS CALL Call 22,900 -37.77 4 -42.86 n/a n/a n/a
2023-04-27 2023-03-31 13F ALNYLAM PHARMACEUTICALS CALL Call 36,800 -28.82 7 -41.67 n/a n/a n/a
2023-02-02 2022-12-31 13F ALNYLAM PHARMACEUTICALS CALL Call 51,700 165.13 12 -99.69 n/a n/a n/a
2022-11-04 2022-09-30 13F ALNYLAM PHARMACEUTICALS CALL Call 19,500 -2.99 3,903 33.16 n/a n/a n/a
2022-08-03 2022-06-30 13F ALNYLAM PHARMACEUTICALS CALL Call 20,100 -35.78 2,931 -42.64 n/a n/a n/a
2022-05-02 2022-03-31 13F ALNYLAM PHARMACEUTICALS CALL Call 31,300 -15.86 5,110 -18.99 n/a n/a n/a
2022-02-23 2021-12-31 13F/A ALNYLAM PHARMACEUTICALS CALL Call 37,200 44.75 6,308 44.61 n/a n/a n/a
2022-02-04 2021-12-31 13F ALNYLAM PHARMACEUTICALS CALL Call 25,700 4,362 n/a n/a n/a
2021-10-28 2021-09-30 13F ALNYLAM PHARMACEUTICALS CALL Call 25,700 0.00 4,362 0.14 n/a n/a n/a
2021-08-12 2021-06-30 13F ALNYLAM PHARMACEUTICALS CALL Call 25,700 71,288.89 4,356 757.48 n/a n/a n/a
2021-04-26 2021-03-31 13F ALNYLAM PHARMACEUTICALS CALL Call 36 -83.93 508 -82.55 n/a n/a n/a
2021-02-02 2020-12-31 13F ALNYLAM PHARMACEUTICALS CALL Call 224 -34.12 2,911 -41.19 n/a n/a n/a
2020-10-14 2020-09-30 13F ALNYLAM PHARMACEUTICALS CALL Call 340 92.09 4,950 88.86 n/a n/a n/a
2020-07-13 2020-06-30 13F ALNYLAM PHARMACEUTICALS CALL Call 177 -68.62 2,621 -57.31 n/a n/a n/a
2020-04-29 2020-03-31 13F ALNYLAM PHARMACEUTICALS CALL Call 564 16.77 6,139 10.37 n/a n/a n/a
2020-02-05 2019-12-31 13F ALNYLAM PHARMACEUTICALS CALL Call 483 -6.21 5,562 34.32 n/a n/a n/a
2019-10-15 2019-09-30 13F ALNYLAM PHARMACEUTICALS CALL Call 515 85.92 4,141 106.12 n/a n/a n/a
2019-07-26 2019-06-30 13F ALNYLAM PHARMACEUTICALS CALL Call 277 25.34 2,009 -2.71 n/a n/a n/a
2019-04-18 2019-03-31 13F ALNYLAM PHARMACEUTICALS CALL Call 221 -24.57 2,065 -3.32 n/a n/a n/a
2019-01-16 2018-12-31 13F ALNYLAM PHARMACEUTICALS CALL Call 293 -52.44 2,136 -60.38 n/a n/a n/a
2018-10-23 2018-09-30 13F ALNYLAM PHARMACEUTICALS CALL Call 616 191.94 5,391 159.43 n/a n/a n/a
2018-07-30 2018-06-30 13F ALNYLAM PHARMACEUTICALS CALL Call 211 31.06 2,078 398.32 n/a n/a n/a
2018-04-26 2018-03-31 13F ALNYLAM PHARMACEUTICALS CALL Call 161 -42.91 417 -35.94 n/a n/a n/a
2018-01-10 2017-12-31 13F ALNYLAM PHARMACEUTICALS CALL Call 282 -55.38 651 -62.02 n/a n/a n/a
2017-10-25 2017-09-30 13F ALNYLAM PHARMACEUTICALS CALL Call 632 89.22 1,714 447.60 n/a n/a n/a
2017-07-12 2017-06-30 13F ALNYLAM PHARMACEUTICALS CALL Call 334 288.37 313 421.67 n/a n/a n/a
2017-04-21 2017-03-31 13F ALNYLAM PHARMACEUTICALS CALL Call 86 -62.28 60 114.29 n/a n/a n/a
2017-01-11 2016-12-31 13F ALNYLAM PHARMACEUTICALS CALL Call 228 46.15 28 -33.33 n/a n/a n/a
2016-10-07 2016-09-30 13F ALNYLAM PHARMACEUTICALS CALL Call 156 -3.70 42 27.27 n/a n/a n/a
2016-07-18 2016-06-30 13F ALNYLAM PHARMACEUTICALS CALL Call 162 189.29 33 106.25 n/a n/a n/a
2016-04-14 2016-03-31 13F ALNYLAM PHARMACEUTICALS CALL Call 56 -70.37 16 -65.22 n/a n/a n/a
2016-01-20 2015-12-31 13F ALNYLAM PHARMACEUTICALS CALL Call 189 7.39 46 100.00 n/a n/a n/a
2015-10-08 2015-09-30 13F ALNYLAM PHARMACEUTICALS CALL Call 176 2,414.29 23 228.57 n/a n/a n/a
2015-07-08 2015-06-30 13F ALNYLAM PHARMACEUTICALS CALL Call 7 -77.42 7 -53.33 n/a n/a n/a
2015-04-21 2015-03-31 13F ALNYLAM PHARMACEUTICALS CALL Call 31 29.17 15 -53.12 n/a n/a n/a
2015-03-04 2014-12-31 13F ALNYLAM PHARMACEUTICALS CALL Call 24 32 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-14 2026-03-31 13F ALNYLAM PHARMACEUTICALS PUT Put 18,200 22.15 6,022 1.64 n/a n/a n/a
2026-02-11 2025-12-31 13F ALNYLAM PHARMACEUTICALS PUT Put 14,900 -43.98 5,925 49,266.67 n/a n/a n/a
2025-11-12 2025-09-30 13F ALNYLAM PHARMACEUTICALS PUT Put 26,600 19.28 12 71.43 n/a n/a n/a
2025-08-05 2025-06-30 13F ALNYLAM PHARMACEUTICALS PUT Put 22,300 -55.31 7 -46.15 n/a n/a n/a
2025-05-12 2025-03-31 13F ALNYLAM PHARMACEUTICALS PUT Put 49,900 72.66 13 116.67 n/a n/a n/a
2025-02-11 2024-12-31 13F ALNYLAM PHARMACEUTICALS PUT Put 28,900 -5.56 7 -25.00 n/a n/a n/a
2024-11-08 2024-09-30 13F ALNYLAM PHARMACEUTICALS PUT Put 30,600 -65.73 8 -61.90 n/a n/a n/a
2024-07-25 2024-06-30 13F ALNYLAM PHARMACEUTICALS PUT Put 89,300 32.49 22 110.00 n/a n/a n/a
2024-04-25 2024-03-31 13F ALNYLAM PHARMACEUTICALS PUT Put 67,400 -10.13 10 -28.57 n/a n/a n/a
2024-02-02 2023-12-31 13F ALNYLAM PHARMACEUTICALS PUT Put 75,000 35.14 14 55.56 n/a n/a n/a
2023-11-01 2023-09-30 13F ALNYLAM PHARMACEUTICALS PUT Put 55,500 50.82 10 50.00 n/a n/a n/a
2023-08-04 2023-06-30 13F ALNYLAM PHARMACEUTICALS PUT Put 36,800 -48.60 7 -57.14 n/a n/a n/a
2023-04-27 2023-03-31 13F ALNYLAM PHARMACEUTICALS PUT Put 71,600 19.73 14 0.00 n/a n/a n/a
2023-02-02 2022-12-31 13F ALNYLAM PHARMACEUTICALS PUT Put 59,800 142.11 14 -99.72 n/a n/a n/a
2022-11-04 2022-09-30 13F ALNYLAM PHARMACEUTICALS PUT Put 24,700 19.90 4,943 64.55 n/a n/a n/a
2022-08-03 2022-06-30 13F ALNYLAM PHARMACEUTICALS PUT Put 20,600 -19.84 3,004 -28.41 n/a n/a n/a
2022-05-02 2022-03-31 13F ALNYLAM PHARMACEUTICALS PUT Put 25,700 -23.96 4,196 -26.78 n/a n/a n/a
2022-02-23 2021-12-31 13F/A ALNYLAM PHARMACEUTICALS PUT Put 33,800 0.60 5,731 0.49 n/a n/a n/a
2022-02-04 2021-12-31 13F ALNYLAM PHARMACEUTICALS PUT Put 33,600 5,703 n/a n/a n/a
2021-10-28 2021-09-30 13F ALNYLAM PHARMACEUTICALS PUT Put 33,600 0.30 5,703 0.44 n/a n/a n/a
2021-08-12 2021-06-30 13F ALNYLAM PHARMACEUTICALS PUT Put 33,500 19,959.88 5,678 140.90 n/a n/a n/a
2021-04-26 2021-03-31 13F ALNYLAM PHARMACEUTICALS PUT Put 167 60.58 2,357 74.46 n/a n/a n/a
2021-02-02 2020-12-31 13F ALNYLAM PHARMACEUTICALS PUT Put 104 -66.88 1,351 -70.44 n/a n/a n/a
2020-10-14 2020-09-30 13F ALNYLAM PHARMACEUTICALS PUT Put 314 -6.82 4,571 -8.42 n/a n/a n/a
2020-07-13 2020-06-30 13F ALNYLAM PHARMACEUTICALS PUT Put 337 -52.33 4,991 -35.14 n/a n/a n/a
2020-04-29 2020-03-31 13F ALNYLAM PHARMACEUTICALS PUT Put 707 -25.66 7,695 -29.74 n/a n/a n/a
2020-02-05 2019-12-31 13F ALNYLAM PHARMACEUTICALS PUT Put 951 82.88 10,952 161.95 n/a n/a n/a
2019-10-15 2019-09-30 13F ALNYLAM PHARMACEUTICALS PUT Put 520 215.15 4,181 249.29 n/a n/a n/a
2019-07-26 2019-06-30 13F ALNYLAM PHARMACEUTICALS PUT Put 165 -55.76 1,197 -65.65 n/a n/a n/a
2019-04-18 2019-03-31 13F ALNYLAM PHARMACEUTICALS PUT Put 373 7.80 3,485 38.18 n/a n/a n/a
2019-01-16 2018-12-31 13F ALNYLAM PHARMACEUTICALS PUT Put 346 -17.03 2,522 -30.89 n/a n/a n/a
2018-10-23 2018-09-30 13F ALNYLAM PHARMACEUTICALS PUT Put 417 787.23 3,649 689.83 n/a n/a n/a
2018-07-30 2018-06-30 13F ALNYLAM PHARMACEUTICALS PUT Put 47 -49.46 462 173.37 n/a n/a n/a
2018-04-26 2018-03-31 13F ALNYLAM PHARMACEUTICALS PUT Put 93 -46.86 169 238.00 n/a n/a n/a
2018-01-10 2017-12-31 13F ALNYLAM PHARMACEUTICALS PUT Put 175 -81.02 50 -27.54 n/a n/a n/a
2017-10-25 2017-09-30 13F ALNYLAM PHARMACEUTICALS PUT Put 922 219.03 69 115.63 n/a n/a n/a
2017-07-12 2017-06-30 13F ALNYLAM PHARMACEUTICALS PUT Put 289 301.39 32 23.08 n/a n/a n/a
2017-04-21 2017-03-31 13F ALNYLAM PHARMACEUTICALS PUT Put 72 -57.40 26 -62.86 n/a n/a n/a
2017-01-11 2016-12-31 13F ALNYLAM PHARMACEUTICALS PUT Put 169 -28.09 70 169.23 n/a n/a n/a
2016-10-07 2016-09-30 13F ALNYLAM PHARMACEUTICALS PUT Put 235 9.81 26 -72.63 n/a n/a n/a
2016-07-18 2016-06-30 13F ALNYLAM PHARMACEUTICALS PUT Put 214 -5.73 95 6.74 n/a n/a n/a
2016-04-14 2016-03-31 13F ALNYLAM PHARMACEUTICALS PUT Put 227 215.28 89 -22.61 n/a n/a n/a
2016-01-20 2015-12-31 13F ALNYLAM PHARMACEUTICALS PUT Put 72 -1.37 115 -37.50 n/a n/a n/a
2015-10-08 2015-09-30 13F ALNYLAM PHARMACEUTICALS PUT Put 73 128.12 184 982.35 n/a n/a n/a
2015-07-08 2015-06-30 13F ALNYLAM PHARMACEUTICALS PUT Put 32 -57.33 17 -19.05 n/a n/a n/a
2015-04-21 2015-03-31 13F ALNYLAM PHARMACEUTICALS PUT Put 75 1,150.00 21 320.00 n/a n/a n/a
2015-03-04 2014-12-31 13F ALNYLAM PHARMACEUTICALS PUT Put 6 5 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.